Citations (5)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (1)
Carmen Alba-Linero, Anna Sala-Puigdollers, Barbara Romero, Victor Llorenç, Alfredo Adan & Javier Zarranz-Ventura. (2020) Long-Term Intravitreal Dexamethasone Implant Outcomes in Uveitis. Ocular Immunology and Inflammation 28:2, pages 228-237.
Read now
Read now
Articles from other publishers (4)
Ioannis Papasavvas, Ilknur Tugal-Tutkun & Carl P. HerbortJr.Jr.. (2022) Mechanisms, Pathophysiology and Current Immunomodulatory/Immunosuppressive Therapy of Non-Infectious and/or Immune-Mediated Choroiditis. Pharmaceuticals 15:4, pages 398.
Crossref
Crossref
Rocco Luigi Modugno, Ilaria Testi & Carlos Pavesio. (2021) Intraocular therapy in noninfectious uveitis. Journal of Ophthalmic Inflammation and Infection 11:1.
Crossref
Crossref
Claudio Iovino, Rodolfo Mastropasqua, Marco Lupidi, Daniela Bacherini, Marco Pellegrini, Federico Bernabei, Enrico Borrelli, Riccardo Sacconi, Adriano Carnevali, Rossella D’Aloisio, Alessio Cerquaglia, Lucia Finocchio, Andrea Govetto, Stefano Erba, Giacinto Triolo, Antonio Di Zazzo, Matteo Forlini, Aldo Vagge & Giuseppe Giannaccare. (2020) Intravitreal Dexamethasone Implant as a Sustained Release Drug Delivery Device for the Treatment of Ocular Diseases: A Comprehensive Review of the Literature. Pharmaceutics 12:8, pages 703.
Crossref
Crossref
. (2019) Dexamethasone. Reactions Weekly 1749:1, pages 170-170.
Crossref
Crossref